Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SPECGX LLC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 34
  • 0 comments

FDA approve DEXTROAMPHETAMINE SULFATE

Comment Full text

BARR

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 35
  • 0 comments

FDA approve DEXTROAMPHETAMINE SULFATE

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 35
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 33
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text

NOVARTIS

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 36
  • 0 comments

FDA approve DEXMETHYLPHENIDATE HYDROCHLORIDE

Comment Full text

NOVARTIS

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 35
  • 0 comments

FDA approve DEXMETHYLPHENIDATE HYDROCHLORIDE

Comment Full text

AYTU BIOPHARMA

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 37
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

SPECGX LLC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 34
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

SPECGX LLC

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 35
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text

NOVARTIS

  • FDA Approval
  • Oct. 17, 2023, 11:43 UTC
  • 34
  • 0 comments

FDA approve METHYLPHENIDATE HYDROCHLORIDE

Comment Full text
  • Previous
  • 655
  • 656
  • 657
  • 658
  • 659
  • Next

Search

News categories

  • Technical Exchange News(13198)
  • Event(6229)
  • SEC News(332596)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(185084)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin